Researchers Encourage More Chlamydia Screening

Published Online: Saturday, January 1, 2005

The reasons for more thorough chlamydia screening are 2-fold. A study, reported in the Annals of Internal Medicine (October 5, 2004), found that more comprehensive screening would likely reduce the frequency of the disease and be cost-effective.

In the study, the researchers found that screening women under the age of 30, and suggesting that any woman who had chlamydia be tested every 6 months rather than only once after diagnosis, would raise health care costs by $107 per woman but would prove cost-effective down the line. "When you take into account the positive effects of screening—not only for the women themselves, but also the benefits from avoiding transmission of the disease to babies or to men—screening becomes cost-saving," said Delphine Hu, MD, PhD, study author.

Dr. Hu explained that the reason for testing relatively older women for the disease reflects current trends: women are marrying later in life and thus have a longer period of sex partners, which increases their risk for chlamydia. Also, screening women every 6 months after they have had chlamydia is wise because those who have had it are 2 times as likely to have a recurrence, compared with those who have never had the disease.

Latest Articles
Pharmacists might be surprised to learn that Pinterest is a hotbed for anti-vaccine sentiment.
The FDA has approved betamethasone dipropionate spray, 0.05%, as a treatment for mild to moderate plaque psoriasis in patients aged 18 years and older.
Medication errors injure thousands of patients annually, and while mistakes occur with all medication classes, those involving antiretroviral therapies are particularly troublesome.
Acute respiratory infections such as the common cold are often accompanied by cough and congestion caused by mucus hypersecretion.
Latest Issues